NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global beta lactam and beta lactamase inhibitors market size is estimated to grow by USD 8.4 billion from ...
Please provide your email address to receive an email when new articles are posted on . A metallo-beta-lactam inhibitor could help fight resistance to beta-lactam antibiotics. MK-3402 was found to be ...
Extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) have become a critical global public health challenge due to their high resistance to β-lactam antibiotics and association with severe ...
MALVERN, Pa.--(BUSINESS WIRE)--Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with difficult-to-treat drug resistant ...
In a study to identify risk factors and outcomes in extended-spectrum beta-lactamose-producing Enterobacteriaceae infections in pediatric patients, researchers found 77 percent of the infections were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback